ACETAMINOPHEN 325 MG

ACETAMINOPHEN 325 MG was reported 99 times

These side effects are most commonly reported by patients taking ACETAMINOPHEN 325 MG:

# Side effect Count
0 INFUSION RELATED REACTION 11
1 CHILLS 7
2 DYSPNOEA 7
3 NAUSEA 7
4 VOMITING 6
5 ALANINE AMINOTRANSFERASE INCREASED 5
6 ASPARTATE AMINOTRANSFERASE INCREASED 5
7 DIZZINESS 5
8 LIVER FUNCTION TEST INCREASED 5
9 PRURITUS 5
10 ABDOMINAL PAIN UPPER 4
11 MENTAL STATUS CHANGES 4
12 PAIN 4
13 CHEST PAIN 3
14 CONFUSIONAL STATE 3
15 COUGH 3
16 DRUG INEFFECTIVE 3
17 FALL 3
18 HAEMOGLOBIN DECREASED 3
19 HEADACHE 3
20 HEPATIC ENZYME INCREASED 3
21 HYPERHIDROSIS 3
22 PAIN IN EXTREMITY 3
23 PYREXIA 3
24 SYNCOPE 3
25 THERAPY INTERRUPTED 3
26 TREMOR 3
27 UNRESPONSIVE TO STIMULI 3
28 ABDOMINAL PAIN 2
29 ACUTE KIDNEY INJURY 2
30 ADVERSE DRUG REACTION 2
31 ASTHENIA 2
32 BLOOD CREATININE INCREASED 2
33 BLOOD PRESSURE DECREASED 2
34 CHEST DISCOMFORT 2
35 CONSTIPATION 2
36 DEPRESSED LEVEL OF CONSCIOUSNESS 2
37 DIARRHOEA 2
38 ELECTROCARDIOGRAM QT PROLONGED 2
39 HAEMOLYTIC ANAEMIA 2
40 HYPERSENSITIVITY 2
41 HYPOXIA 2
42 MELAENA 2
43 MUSCULOSKELETAL STIFFNESS 2
44 RASH 2
45 RECTAL HAEMORRHAGE 2
46 REFUSAL OF TREATMENT BY PATIENT 2
47 TACHYCARDIA 2
48 THERAPY CESSATION 2
49 TRANSAMINASES INCREASED 2
50 VISION BLURRED 2
51 ABDOMINAL DISTENSION 1
52 ABNORMAL BEHAVIOUR 1
53 ACUTE LUNG INJURY 1
54 ANHEDONIA 1
55 ANXIETY 1
56 APPETITE DISORDER 1
57 ARTERIOVENOUS MALFORMATION 1
58 ARTHRALGIA 1
59 ATRIAL FIBRILLATION 1
60 ATRIAL FLUTTER 1
61 BACK PAIN 1
62 BASILAR ARTERY ANEURYSM 1
63 BLISTER 1
64 BLOOD ALKALINE PHOSPHATASE INCREASED 1
65 BLOOD CREATINE PHOSPHOKINASE DECREASED 1
66 BLOOD GLUCOSE INCREASED 1
67 BLOOD PRESSURE FLUCTUATION 1
68 BLOOD PRESSURE INCREASED 1
69 BODY TEMPERATURE INCREASED 1
70 BRONCHITIS 1
71 BRUXISM 1
72 BURKHOLDERIA TEST POSITIVE 1
73 BURNING SENSATION 1
74 C-REACTIVE PROTEIN INCREASED 1
75 CAPILLARY LEAK SYNDROME 1
76 CARDIAC ARREST 1
77 CARDIOVERSION 1
78 CEREBRAL ARTERY STENOSIS 1
79 CLOSTRIDIUM DIFFICILE INFECTION 1
80 COLITIS 1
81 COLITIS ULCERATIVE 1
82 CONTUSION 1
83 COVID-19 1
84 CREATININE RENAL CLEARANCE DECREASED 1
85 DECREASED ACTIVITY 1
86 DEEP VEIN THROMBOSIS 1
87 DEMENTIA 1
88 DEPRESSION 1
89 DIZZINESS POSTURAL 1
90 DROOLING 1
91 DRUG DISPENSING ERROR 1
92 DRUG-INDUCED LIVER INJURY 1
93 DYSPHAGIA 1
94 ECCHYMOSIS 1
95 ECONOMIC PROBLEM 1
96 EMOTIONAL DISTRESS 1
97 EPISTAXIS 1
98 EYE DISORDER 1
99 EYE IRRITATION 1
100 EYE PAIN 1
101 FATIGUE 1
102 FEAR 1
103 FEELING ABNORMAL 1
104 FEELING COLD 1
105 FLUSHING 1
106 GAIT DISTURBANCE 1
107 GASTRIC INFECTION 1
108 GASTROINTESTINAL HAEMORRHAGE 1
109 GENERAL PHYSICAL HEALTH DETERIORATION 1
110 GENITAL BLISTER 1
111 HAEMATOCHEZIA 1
112 HAEMATOMA 1
113 HAEMORRHAGE 1
114 HAEMORRHAGE INTRACRANIAL 1
115 HEAD INJURY 1
116 HEART RATE DECREASED 1
117 HEPATIC FUNCTION ABNORMAL 1
118 HYPERTENSION 1
119 HYPOALBUMINAEMIA 1
120 HYPOGLYCAEMIA 1
121 HYPOMAGNESAEMIA 1
122 HYPOPHAGIA 1
123 HYPOTENSION 1
124 IMPAIRED HEALING 1
125 INCORRECT DRUG DOSAGE FORM ADMINISTERED 1
126 INFLAMMATION 1
127 INFUSION SITE EXTRAVASATION 1
128 INFUSION SITE PAIN 1
129 INFUSION SITE SWELLING 1
130 INJECTION SITE ERYTHEMA 1
131 INJECTION SITE PAIN 1
132 INJECTION SITE PRURITUS 1
133 INJECTION SITE REACTION 1
134 INJECTION SITE WARMTH 1
135 INSOMNIA 1
136 INTELLECTUAL DISABILITY 1
137 INTENTIONAL DOSE OMISSION 1
138 INTERNATIONAL NORMALISED RATIO DECREASED 1
139 LABORATORY TEST INTERFERENCE 1
140 LOSS OF CONSCIOUSNESS 1
141 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1
142 MALAISE 1
143 MIGRAINE 1
144 MUSCLE RELAXANT DRUG LEVEL ABOVE THERAPEUTIC 1
145 MUSCLE RIGIDITY 1
146 MUSCLE SPASMS 1
147 MUSCULAR WEAKNESS 1
148 MUSCULOSKELETAL CHEST PAIN 1
149 NECROTISING SOFT TISSUE INFECTION 1
150 NO ADVERSE EVENT 1
151 OCCULT BLOOD POSITIVE 1
152 OEDEMA 1
153 OFF LABEL USE 1
154 OLIGURIA 1
155 ORAL DISCOMFORT 1
156 ORGANISING PNEUMONIA 1
157 OSTEOPENIA 1
158 OSTEOPOROSIS 1
159 OVERDOSE 1
160 OXYGEN SATURATION ABNORMAL 1
161 OXYGEN SATURATION DECREASED 1
162 PALPITATIONS 1
163 PARAESTHESIA 1
164 PHARYNGEAL DISORDER 1
165 PHYSICAL PRODUCT LABEL ISSUE 1
166 PNEUMONIA 1
167 POST PROCEDURAL COMPLICATION 1
168 PRERENAL FAILURE 1
169 PRESYNCOPE 1
170 PRODUCT DOSE OMISSION ISSUE 1
171 PRODUCT LABEL CONFUSION 1
172 PRODUCT QUALITY ISSUE 1
173 QUALITY OF LIFE DECREASED 1
174 RASH GENERALISED 1
175 RECALLED PRODUCT 1
176 RECALLED PRODUCT ADMINISTERED 1
177 RECTAL ULCER 1
178 RESTLESSNESS 1
179 RETROPERITONEAL HAEMATOMA 1
180 RHABDOMYOLYSIS 1
181 SEIZURE 1
182 SERUM FERRITIN INCREASED 1
183 SHOCK 1
184 SINUSITIS 1
185 SOCIAL AVOIDANT BEHAVIOUR 1
186 SPEECH DISORDER 1
187 STATUS EPILEPTICUS 1
188 STOMATITIS 1
189 STUPOR 1
190 SUBDURAL HAEMATOMA 1
191 TENDON RUPTURE 1
192 THERAPY NON-RESPONDER 1
193 TORSADE DE POINTES 1
194 TOXICITY TO VARIOUS AGENTS 1
195 URINARY INCONTINENCE 1
196 URINARY TRACT INFECTION 1
197 URTICARIA 1
198 VENTRICULAR EXTRASYSTOLES 1
199 VENTRICULAR TACHYCARDIA 1
200 VERTEBRAL ARTERY STENOSIS 1
201 WEIGHT DECREASED 1
202 WEIGHT INCREASED 1
203 WHITE BLOOD CELL COUNT DECREASED 1
204 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1